More details may be found at FASS Allmänhet:  https://www.fass.se/LIF/product?userType=2&nplId=20161201000085

Product Details

Anagrelide AOP is indicated for the reduction of elevated platelet counts and associated clinical symptoms in at high risk essential thrombocythemia patients.